Bcl-G Inhibitors

Bcl-G inhibitors as a chemical class are not well-defined due to the absence of direct inhibitors specific to Bcl-G. However, the class of compounds that can act as indirect inhibitors generally targets the broader Bcl-2 family of proteins. These compounds modulate the delicate balance between pro-apoptotic and anti-apoptotic proteins, thereby influencing apoptosis, a process in which Bcl-G is involved. The members of this chemical class often mimic the structure of BH3-only proteins or bind to the same domains on pro-survival Bcl-2 family members that BH3-only proteins would typically interact with.

Inhibitors of Bcl-G function indirectly by modulating the activity of the broader Bcl-2 family of proteins. These proteins play a key role in the intrinsic pathway of apoptosis, which is a form of programmed cell death that occurs in response to internal signals. The Bcl-2 family is composed of both pro-apoptotic and anti-apoptotic members, and the balance between these determines the cell's fate. Inhibitors that target pro-survival Bcl-2 family proteins can shift this balance in favor of cell death, thereby counteracting the anti-apoptotic function of Bcl-G.